how to reconstitute 5-amino-1mq peptide 5-Amino-1MQ Research Compound | >99%

By inhibiting NNMT, the body maintains higher NAD levels, which in turn activate SIRT1, a longevity-associated gene, which may improve mitochondrial activity, fat oxidation, insulin sensitivity, and by overall energy balance

The decision to continue, adjust, or discontinue therapy should be based on objective body composition measurements (DEXA scans, circumference measurements), achievement of fat loss goals, tolerance and side effect profile, and physician assessment of metabolic markers

Ongoing Monitoring and Support We provide continued follow-up to monitor progress, ensure safety, and optimize outcomes

Allergic reactions Rare but may include itching, rash, or difficulty breathin Always consult a healthcare provider if side effects persist or worsen

At Cenexa Labs, we manufacture our own peptides under strict USA-based standardsright here IN THE USA

Phase 2: Introduce AOD 9604 (weeks 5-8) Once tirzepatide is tolerated at the initial dose, add AOD 9604 at 250mcg daily